Hikma Pharmaceuticals PLC HIK shares shed 1.04% to £19.93 Friday, on what proved to be an all-around grim trading session for ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.05% to £20.14 Thursday, on what proved to be an all-around favorable ...

In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K.

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...

Hikma Pharmaceuticals announced a transaction involving the disposal of shares by a Person Discharging Managerial Responsibilities (PDMR), Susan Ringdal. The transaction involved the sale of 3,300 ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...